Literature DB >> 12529874

Applications of continuous time hidden Markov models to the study of misclassified disease outcomes.

Alexandre Bureau1, Stephen Shiboski, James P Hughes.   

Abstract

Disease progression in prospective clinical and epidemiological studies is often conceptualized in terms of transitions between disease states. Analysis of data from such studies can be complicated by a number of factors, including the presence of individuals in various prevalent disease states and with unknown prior disease history, interval censored observations of state transitions and misclassified measurements of disease states. We present an approach where the disease states are modelled as the hidden states of a continuous time hidden Markov model using the imperfect measurements of the disease state as observations. Covariate effects on transitions between disease states are incorporated using a generalized regression framework. Parameter estimation and inference are based on maximum likelihood methods and rely on an EM algorithm. In addition, techniques for model assessment are proposed. Applications to two binary disease outcomes are presented: the oral lesion hairy leukoplakia in a cohort of HIV infected men and cervical human papillomavirus (HPV) infection in a cohort of young women. Estimated transition rates and misclassification probabilities for the hairy leukoplakia data agree well with clinical observations on the persistence and diagnosis of this lesion, lending credibility to the interpretation of hidden states as representing the actual disease states. By contrast, interpretation of the results for the HPV data are more problematic, illustrating that successful application of the hidden Markov model may be highly dependent on the degree to which the assumptions of the model are satisfied. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529874     DOI: 10.1002/sim.1270

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified.

Authors:  Julia S Benoit; Wenyaw Chan; Sheng Luo; Hung-Wen Yeh; Rachelle Doody
Journal:  Stat Med       Date:  2016-01-18       Impact factor: 2.373

2.  Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models.

Authors:  Andrew C Titman
Journal:  Lifetime Data Anal       Date:  2009-11-01       Impact factor: 1.588

3.  Qualitative longitudinal analysis of symptoms in patients with primary and metastatic brain tumours.

Authors:  Frank Rijmen; Edward H Ip; Stephen Rapp; Edward G Shaw
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2008       Impact factor: 2.483

4.  Fitting and interpreting continuous-time latent Markov models for panel data.

Authors:  Jane M Lange; Vladimir N Minin
Journal:  Stat Med       Date:  2013-06-05       Impact factor: 2.373

5.  A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies.

Authors:  Serge Aleshin-Guendel; Jane Lange; Phyllis Goodman; Noel S Weiss; Ruth Etzioni
Journal:  Eval Health Prof       Date:  2021-01-28       Impact factor: 2.651

6.  Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics.

Authors:  Xiangrong Kong; Mei-Cheng Wang; Ronald Gray
Journal:  J Am Stat Assoc       Date:  2015-06-01       Impact factor: 5.033

7.  Classification of disease recurrence using transition likelihoods with expectation-maximization algorithm.

Authors:  Huijun Jiang; Quefeng Li; Jessica T Lin; Feng-Chang Lin
Journal:  Stat Med       Date:  2022-07-31       Impact factor: 2.497

8.  Bayesian continuous-time hidden Markov models with covariate selection for intensive longitudinal data with measurement error.

Authors:  Mingrui Liang; Matthew D Koslovsky; Emily T Hébert; Darla E Kendzor; Michael S Businelle; Marina Vannucci
Journal:  Psychol Methods       Date:  2021-12-20

9.  Kinetics methods for clinical epidemiology problems.

Authors:  Alexandru Dan Corlan; John Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

10.  Progression of liver cirrhosis to HCC: an application of hidden Markov model.

Authors:  Nicola Bartolomeo; Paolo Trerotoli; Gabriella Serio
Journal:  BMC Med Res Methodol       Date:  2011-04-04       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.